Item request has been placed!
×
Item request cannot be made.
×
Processing Request
Item request has been placed!
×
Item request cannot be made.
×
Processing Request
-
Authors :
Wittwer NL; Translational Oncology Laboratory, Centre for Cancer Biology, SA Pathology, University of South Australia, Adelaide, SA, 5000, Australia. .; Adelaide Medical School, University of Adelaide, Adelaide, SA, 5000, Australia. .
Subjects: Immunoconjugates*/Immunoconjugates*/Immunoconjugates*/pharmacology ; Immunoconjugates*/Immunoconjugates*/Immunoconjugates*/therapeutic use ; Antineoplastic Agents*/Antineoplastic Agents*/Antineoplastic Agents*/pharmacology
-
Source:
Journal of experimental & clinical cancer research : CR [J Exp Clin Cancer Res] 2023 Oct 25; Vol. 42 (1), pp. 280. Date of Electronic Publication: 2023 Oct 25.Publisher: BioMed Central Country of Publication: England NLM ID: 8308647 Publication Model: Electronic Cited Medium:
Record details
-
Authors :
Fu Z; Department of Pharmacy, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei Province, China.; Hubei Province Clinical Research Center for Precision Medicine for Critical Illness, 1277 Jiefang Avenue, Jianghan District, Wuhan, Hubei Province, 430000, China.
Subjects: Immunoconjugates*/Immunoconjugates*/Immunoconjugates*/adverse effects ; Neoplasms*/Neoplasms*/Neoplasms*/drug therapy ; Pneumonia*
-
Source:
BMC cancer [BMC Cancer] 2023 Oct 10; Vol. 23 (1), pp. 960. Date of Electronic Publication: 2023 Oct 10.Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium:
Record details
-
Authors :
Jain N; Division of Cancer Biology, CSIR-Central Drug Research Institute, Lucknow, Uttar Pradesh, India.; Academy of Scientific and Innovative Research, Ghaziabad, Uttar Pradesh, 201002, India.
Subjects: Lymphoma, Mantle-Cell*/Lymphoma, Mantle-Cell*/Lymphoma, Mantle-Cell*/drug therapy ; Antibodies, Bispecific*/Antibodies, Bispecific*/Antibodies, Bispecific*/pharmacology ; Antibodies, Bispecific*/Antibodies, Bispecific*/Antibodies, Bispecific*/therapeutic use
-
Source:
Journal of hematology & oncology [J Hematol Oncol] 2023 Aug 25; Vol. 16 (1), pp. 99. Date of Electronic Publication: 2023 Aug 25.Publisher: Biomed Central Country of Publication: England NLM ID: 101468937 Publication Model: Electronic Cited Medium:
Record details
